Review
Published on 12 Oct 2023
The relationship between cancer and biomechanics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1273154
- 6,168 views
- 15 citations
Type at least 3 characters
3,056 articles
Review
Published on 11 Oct 2023
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1222575
- 3,987 views
- 8 citations
Retraction
Published on 10 Oct 2023
Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1298871
- 1,467 views
- 1 citation
Editorial
Published on 09 Oct 2023
Editorial: Tumour microenvironment heterogeneity in hematological malignancies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1295996
- 1,423 views
Case Report
Published on 09 Oct 2023
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1252359
- 2,461 views
- 2 citations
Review
Published on 03 Oct 2023
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1215194
- 3,241 views
- 4 citations
Review
Published on 02 Oct 2023
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1202117
- 5,373 views
- 10 citations
Original Research
Published on 29 Sep 2023
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1166666
- 2,450 views
- 5 citations
Original Research
Published on 28 Sep 2023
Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1137966
- 2,777 views
Editorial
Published on 28 Sep 2023
Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1289756
- 1,878 views
Perspective
Published on 26 Sep 2023
Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1278402
- 1,505 views
- 1 citation
Review
Published on 26 Sep 2023
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1251100
- 12,088 views
- 17 citations
Review
Published on 26 Sep 2023
Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1256585
- 4,882 views
- 11 citations
Review
Published on 22 Sep 2023
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1184079
- 18,487 views
- 61 citations
Review
Published on 21 Sep 2023
Evolution by innovation as a driving force to improve TCR-T therapies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1216829
- 6,973 views
- 3 citations
Review
Published on 20 Sep 2023
Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1265347
- 6,595 views
- 18 citations